Elanco Animal Health Inc (ELAN) Q2 2026 Earnings
As seen on the 24/7 Wall St. homepage on August 5, 2026.
Q2 2026
EPS
$0.34
est $0.27
+26.4%
Revenue
$1.37B
est $1.31B
+4.2%
Zenrelia is now in roughly 18,000 US clinics, driving a 26% EPS beat that lifted full-year adjusted EPS guidance to $1.10 to $1.16. Credelio Quattro already covers more than half the US clinic base, so the innovation ramp has room to run into Q3.
Mentioned: ELAN